A chimeric IgG4 monoclonal antibody directed against CD18 reduces infarct size in a primate model of myocardial ischemia and reperfusion
Open Access
- 1 March 1995
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 25 (3) , 781-788
- https://doi.org/10.1016/0735-1097(94)00443-t
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemie myocardiumPublished by Elsevier ,2002
- Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liverHepatology, 1993
- Endothelial-Leukocyte Adhesion MoleculesAnnual Review of Immunology, 1993
- Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion.Journal of Clinical Investigation, 1991
- Determinants of infarct size in non-human primatesBasic Research in Cardiology, 1990
- Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion.Journal of Clinical Investigation, 1988
- A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary AngioplastyNew England Journal of Medicine, 1987
- Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Variability in the measurement of regional left ventricular wall motion from contrast angiograms.Circulation, 1983
- The use of single plane angiocardiograms for the calculation of left ventricular volume in manAmerican Heart Journal, 1968